TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study.

Radhakrishnan Ramchandren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.